HCPLive Network

Flu Vaccine Approved

The FDA announced last week that it had approved the formulation of the 2011-2012 influenza vaccine for the six manufacturers that are licensed to produce and distribute it in the US.
 
Each year, the vaccine contains the three virus strains determined to be those likely to cause the most illness during the upcoming flu season. This year’s vaccine includes the same three strains as last year’s, though those who received the vaccine last year should not be tempted to skip this year’s.
 
“It is important to get vaccinated every year, even if the strains in the vaccine do not change, because the protection received the previous year will diminish over time and may be too low to provide protection into the next year,” said Karen Midthun, MD, director of FDA’s Center for Biologics Evaluation and Research, in a press release.
 
The brand names and manufacturers of vaccine for the upcoming flu season are: Afluria (CSL Limited); Fluarix (GlaxoSmithKline Biologicals); FluLaval (ID Biomedical Corporation); FluMist (MedImmune Vaccines Inc.); Fluvirin (Novartis Vaccines and Diagnostics Limited); and Fluzone, Fluzone High-Dose, and Fluzone Intradermal (Sanofi Pasteur Inc.). (Fluzone Intradermal is delivered via a very small needle into the skin rather than muscle and is available for those aged 18 to 64.)
 
Around the Web
 
FDA approves vaccines for the 2011-2012 influenza season [FDA] 
Further Reading
Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.
With so many factors to consider in the treatment of multiple sclerosis, the panelists identify several “unmet needs” of patients with multiple sclerosis and discuss several options for managing them.
An emerging epidemic of acute hepatitis C threatens the country’s younger population, which experienced a significant hike in the number of cases during a recent 6 year period, according to a compound study that looked at trends of the disease among youth.
Nurses who have high levels of prosocial motivation are more likely to report job burnout, according to research presented at the annual meeting of the American Sociological Association, held from Aug. 16 to 19 in San Francisco.
A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.
The gender of siblings appears to influence parent caregiving, according to research presented at the annual meeting of the American Sociological Association, held from Aug. 16 to 19 in San Francisco.
There is a strong association between severe untreated obstructive sleep apnea and resistant elevated blood pressure, despite treatment with an aggressive antihypertensive medication regimen, according to a study published in the August issue of the Journal of Clinical Sleep Medicine.
More Reading